Gladstone Institutional Advisory’s Innovator US Equity 10 Buffer ETF Quarterly ZALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.23M Buy
130,454
+46,352
+55% +$1.52M 0.16% 148
2025
Q4
$2.74M Sell
84,102
-1,850
-2% -$59.6K 0.1% 210
2025
Q3
$2.74M Sell
85,952
-12,025
-12% -$378K 0.11% 196
2025
Q2
$3.02M Sell
97,977
-19,475
-17% -$585K 0.12% 176
2025
Q1
$3.5M Sell
117,452
-384
-0.3% -$11.5K 0.16% 147
2024
Q4
$3.51M Buy
117,836
+76,955
+188% +$2.29M 0.16% 150
2024
Q3
$1.2M Buy
+40,881
New +$1.17M 0.06% 297

Other funds holding ZALT

Gladstone Institutional Advisory's ZALT Position: Q1 2026 in Review

Gladstone Institutional Advisory increased its Innovator US Equity 10 Buffer ETF Quarterly (ZALT) stake by 55% in Q1 2026, buying an estimated $1.52M and bringing the position to 130,454 shares worth $4.23M. The position accounts for 0.16% of the portfolio, ranked #148.

Gladstone Institutional Advisory first reported a position in ZALT in Q3 2024 and has held it in 7 quarters since. 103 funds tracked by Wall St. Rank hold ZALT as of Q1 2026.

  • Gladstone Institutional Advisory held 130,454 shares of Innovator US Equity 10 Buffer ETF Quarterly worth $4.23M as of Q1 2026.
  • Gladstone Institutional Advisory bought 46,352 Innovator US Equity 10 Buffer ETF Quarterly shares in Q1 2026, an estimated $1.52M.
  • Innovator US Equity 10 Buffer ETF Quarterly made up 0.16% of Gladstone Institutional Advisory's portfolio in Q1 2026, its #148 holding.
  • Gladstone Institutional Advisory first reported a position in Innovator US Equity 10 Buffer ETF Quarterly in Q3 2024 and has held it in 7 quarters since.
  • 103 funds tracked by Wall St. Rank held Innovator US Equity 10 Buffer ETF Quarterly as of Q1 2026.

Based on Gladstone Institutional Advisory's 13F filing for Q1 2026, filed 14 May 2026.